▼ 0.55%
prev close
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
Congressional Trades
13
All tracked trades
Members Trading
9
Unique members
Net Activity
+1
7 buys · 6 sells
Members Who Traded This Stock
13 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2025-12-18 | ABTAbbott Laboratories Common Stock | Sell | $1,001 - $15,000 | 139d ago | — | |
| 2025-11-13 | ABTAbbott Laboratories Common Stock | Sell | $1,001 - $15,000 | 174d ago | — | |
| 2025-08-14 | ABTAbbott Laboratories Common Stock | Sell | $1,001 - $15,000 | 265d ago | — | |
| 2025-06-24 | ABTAbbott Laboratories Common Stock | Buy | $1,001 - $15,000 | 294d ago | — | |
| 2025-05-12 | ABTAbbott Laboratories Common Stock | Sell | $50,001 - $100,000 | 346d ago | — | |
| 2025-01-28 | ABTAbbott Laboratories Common Stock | Buy | $1,001 - $15,000 | 478d ago | — | |
| 2024-10-23 | ABTAbbott Laboratories Common Stock | Buy | $1,001 - $15,000 | 141d ago | — | |
| 2024-07-29 | ABTAbbott Laboratories Common Stock | Buy | $1,001 - $15,000 | 657d ago | — | |
| 2024-07-02 | ABTAbbott Laboratories Common Stock | Buy | $1,001 - $15,000 | 656d ago | — | |
| 2024-01-23 | ABTAbbott Laboratories Common Stock | Sell | $1,001 - $15,000 | 848d ago | — | |
| 2023-09-26 | ABTAbbott Laboratories Common Stock | Buy | $1,001 - $15,000 | 937d ago | — | |
| 2023-03-06 | ABTAbbott Laboratories Common Stock | Sell | $50,001 - $100,000 | 1143d ago | — | |
| 2019-09-27 | ABTAbbott Laboratories Common Stock | Buy | $15,001 - $50,000 | 1028d ago | — |
2025-12-18
Julie Johnson
ABT
Amount
$1,001 - $15,000
Filed
139d ago
2025-11-13
Julie Johnson
ABT
Amount
$1,001 - $15,000
Filed
174d ago
2025-08-14
Julie Johnson
ABT
Amount
$1,001 - $15,000
Filed
265d ago
2025-06-24
Lisa McClain
ABT
Amount
$1,001 - $15,000
Filed
294d ago
2025-05-12
Jefferson Shreve
ABT
Amount
$50,001 - $100,000
Filed
346d ago
2025-01-28
Josh Gottheimer
ABT
Amount
$1,001 - $15,000
Filed
478d ago
2024-10-23
Julia Letlow
ABT
Amount
$1,001 - $15,000
Filed
141d ago
2024-07-29
Josh Gottheimer
ABT
Amount
$1,001 - $15,000
Filed
657d ago
2024-07-02
Kathy Manning
ABT
Amount
$1,001 - $15,000
Filed
656d ago
2024-01-23
Kathy Manning
ABT
Amount
$1,001 - $15,000
Filed
848d ago
2023-09-26
Greg Stanton
ABT
Amount
$1,001 - $15,000
Filed
937d ago
2023-03-06
Daniel Goldman
ABT
Amount
$50,001 - $100,000
Filed
1143d ago
2019-09-27
Richard W. Allen
ABT
Amount
$15,001 - $50,000
Filed
1028d ago
Recent News
Powered by Polygon.io
Protein Supplements Market to Grow at 7.7% CAGR by 2031 Fueled by Rising Sports Nutrition Demand and Health and Wellness Trends, Reports Mordor Intelligence
Peripheral Vascular Devices Market by Type, End User - Global Forecast to 2031
3 Beaten-Down Stocks to Buy and Hold Forever
JenaValve Appoints Edward Sarnowski as Chief Technology Officer
Why Johnson & Johnson Might Be the Smartest Dividend King to Buy in Today's Market
Trade Timeline
Congressional activity, newest first
Julie Johnson
2025-12-18 · Sale
$1,001 - $15,000
Julie Johnson
2025-11-13 · Sale
$1,001 - $15,000
Julie Johnson
2025-08-14 · Sale
$1,001 - $15,000
Lisa McClain
2025-06-24 · Purchase
$1,001 - $15,000
Jefferson Shreve
2025-05-12 · Sale
$50,001 - $100,000
Josh Gottheimer
2025-01-28 · Purchase
$1,001 - $15,000
Julia Letlow
2024-10-23 · Purchase
$1,001 - $15,000
Josh Gottheimer
2024-07-29 · Purchase
$1,001 - $15,000
Kathy Manning
2024-07-02 · Purchase
$1,001 - $15,000
Kathy Manning
2024-01-23 · Sale
$1,001 - $15,000
Greg Stanton
2023-09-26 · Purchase
$1,001 - $15,000
Daniel Goldman
2023-03-06 · Sale
$50,001 - $100,000
Richard W. Allen
2019-09-27 · Purchase
$15,001 - $50,000